Business Case for Financial Transformation in Clinical Trials

This white paper outlines the business case for implementing comprehensive financial transformation solutions in clinical trials, focusing on the challenges faced by research sites and sponsors regarding site payments. A satisfaction survey conducted by Greenphire indicates that 82% of sites experience negative impacts on operations due to delayed payments from sponsors. The paper details the complexities of managing site payments manually, which can lead to inefficiencies, errors, and increased costs. It discusses the collaboration with Hobson & Company, which conducted interviews with Greenphire clients to validate the effectiveness of their EnvisiX and eClinicalGPS solutions. The document highlights key operational benefits, including streamlined workflows, improved accuracy and transparency, and enhanced site and participant satisfaction. It emphasizes the importance of reducing time spent on budgeting, payment management, and study close-outs, ultimately demonstrating that every dollar invested in Greenphire solutions can yield a significant return on investment.